Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Upcoming)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI115527

Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis.

X Sáez-Llorens, H S Jafari, C Severien, F Parras, K D Olsen, E J Hansen, I I Singer, and G H McCracken Jr

Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235-9063.

Find articles by Sáez-Llorens, X. in: JCI | PubMed | Google Scholar

Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235-9063.

Find articles by Jafari, H. in: JCI | PubMed | Google Scholar

Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235-9063.

Find articles by Severien, C. in: JCI | PubMed | Google Scholar

Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235-9063.

Find articles by Parras, F. in: JCI | PubMed | Google Scholar

Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235-9063.

Find articles by Olsen, K. in: JCI | PubMed | Google Scholar

Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235-9063.

Find articles by Hansen, E. in: JCI | PubMed | Google Scholar

Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235-9063.

Find articles by Singer, I. in: JCI | PubMed | Google Scholar

Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235-9063.

Find articles by McCracken, G. in: JCI | PubMed | Google Scholar

Published December 1, 1991 - More info

Published in Volume 88, Issue 6 on December 1, 1991
J Clin Invest. 1991;88(6):2003–2011. https://doi.org/10.1172/JCI115527.
© 1991 The American Society for Clinical Investigation
Published December 1, 1991 - Version history
View PDF
Abstract

Antiinflammatory therapy has been shown to reduce the adverse pathophysiological consequences that occur in bacterial meningitis and to improve outcome from disease. In the present study, modulation of two principal steps of the meningeal inflammatory cascade was accomplished by concomitant administration of dexamethasone to diminish overproduction of cytokines in response to a bacterial stimulus and of a monoclonal antibody directed against adhesion-promoting receptors on leukocytes to inhibit recruitment of white blood cells into the subarachnoid space. Dexamethasone and antibody therapy produced a marked attenuation of all indices of meningeal inflammation and reduction of brain water accumulation after H. influenzae-induced meningitis in rabbits compared with results of each agent given alone and of untreated animals. In addition, the enhanced host's meningeal inflammatory reaction that follows antibiotic-induced bacterial lysis was profoundly ameliorated when dual therapy was administered without affecting clearance rates of bacteria from cerebrospinal fluid and vascular compartments. The combination of both therapeutic approaches may offer a promising mode of treatment to improve further the outcome from bacterial meningitis.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2003
page 2003
icon of scanned page 2004
page 2004
icon of scanned page 2005
page 2005
icon of scanned page 2006
page 2006
icon of scanned page 2007
page 2007
icon of scanned page 2008
page 2008
icon of scanned page 2009
page 2009
icon of scanned page 2010
page 2010
icon of scanned page 2011
page 2011
Version history
  • Version 1 (December 1, 1991): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts